Stephen Palmer
Impact in
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Pharmaceutical Economics and Policy
- Emergency Medical Services top 1%
- Healthcare Operations and Scheduling Optimization
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 58
- Pharmaceutical Economics and Policy 16
- Healthcare Policy and Management 8
- Economic and Financial Impacts of Cancer 6
-
- Statistical Methods in Clinical Trials 10
- Co-authors
- Mark SculpherKarl ClaxtonKeith R. AbramsLaura BojkeSofia DiasNicky J. WeltonA. E. AdesNerys Woolacott
- Journals
- Health Technology Assessment (32 papers)Value in Health (20 papers)PharmacoEconomics (13 papers)Medical Decision Making (8 papers)Heart (6 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Stephen Palmer
145 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Economics and Econometrics 1.7k
- Emergency Medical Services 336
- Otorhinolaryngology 198
- Periodontics 199
- Statistics and Probability 274
Countries citing papers authored by Stephen Palmer
This map shows the geographic impact of Stephen Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Palmer more than expected).
Fields of papers citing papers by Stephen Palmer
This network shows the impact of papers produced by Stephen Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Palmer. The network helps show where Stephen Palmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A | 2022 | 14 |
| 5 | 2022 | 6 | |
| 6 | 2021 | 13 | |
| 7 | 2018 | 18 | |
| 8 | 2017 | 14 | |
| 9 | 2015 | 19 | |
| 10 | 2014 | 27 | |
| 11 | 2012 | 14 | |
| 12 | 2010 | 38 | |
| 13 | 2010 | 41 | |
| 14 | 2008 | 57 | |
| 15 | Dangerous Omissions: The Consequences of Ignoring Decision Uncertainty | 2007 | 4 |
| 16 | 2006 | 160 | |
| 17 | 2006 | 142 | |
| 18 | 2006 | 27 | |
| 19 | 2004 | 64 | |
| 20 | 2003 | 406 |
About Stephen Palmer
Stephen Palmer is a scholar working on Economics and Econometrics, Statistics and Probability, Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Internal Medicine, having authored 154 papers that have together received 5.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (58 papers), Pharmaceutical Economics and Policy (16 papers), Healthcare cost, quality, practices (15 papers), Statistical Methods in Clinical Trials (10 papers), Acute Myocardial Infarction Research (9 papers), Healthcare Policy and Management (8 papers), Economic and Financial Impacts of Cancer (6 papers) and Atrial Fibrillation Management and Outcomes (6 papers). The work is most often cited by research in Economics and Econometrics (1.7k citations), Emergency Medical Services (336 citations), Otorhinolaryngology (198 citations), Periodontics (199 citations) and Statistics and Probability (274 citations). Stephen Palmer has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Mark Sculpher, Karl Claxton, Keith R. Abrams, Laura Bojke, Sofia Dias, Nicky J. Welton, A. E. Ades, Nerys Woolacott, David Phillippo and Z Philips. Their work appears in journals such as Health Technology Assessment, Value in Health, PharmacoEconomics, Medical Decision Making and Heart.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.